Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
3 May 2017
E-003085-17
Question for written answer
to the Commission
Rule 130
Roberta Metsola (PPE)

 Subject:  Pricing and accessibility of medicines
 Answer(s) 

Consumers view medicines as unaffordable and their accessibility is also deemed problematic in a number of Member States. As a result, the debate on the affordability and accessibility of medicines has taken centre stage in the EU and its Member States.

What is the Commission doing in order to make medicines more affordable and to increase their accessibility in similar fashion in all the Member States of the European Union?

Last updated: 16 May 2017Legal notice